The lipid phosphatase activity of pten and its ability to dephosphorylate pip3 and act as a “countermeasure” for pi3k signalling suggests that pten functions as a significant tumour suppressor by directly antagonizing the activity of the pi3k/Akt signalling pathway (Figure 1). This evidence concerns the gene AKT1 and neoplasm.